15.20
+2.60
+(20.63%)
At close: April 10 at 8:27:22 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 330.82M | 340.2M | 1.37B | 1.51B |
| Low Estimate | 323.16M | 325M | 1.36B | 1.47B |
| High Estimate | 347.08M | 352.78M | 1.39B | 1.56B |
| Year Ago Sales | 300.58M | 311.15M | 1.17B | 1.37B |
| Sales Growth (year/est) | 10.06% | 9.34% | 17.42% | 9.71% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 850.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 4/3/2025 |
| Reiterates | Needham: Buy to Buy | 4/3/2025 |
| Maintains | Rosenblatt: Buy to Buy | 4/3/2025 |
| Initiated | JP Morgan: Neutral | 3/31/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/9/2025 |
| Maintains | Needham: Buy to Buy | 1/9/2025 |